Stock screener

PRTA

Conviction 50HealthcareScan · Thu, Jun 25, 2026
PRTA$9.27-1.38%
ResistanceSupportVol 14Insider buy
63 bars
Vol MA14 668.14K
Mar 26Apr 14May 1May 19Jun 8Jun 25
PROTHENA CORP PUBLIC LTD COPHARMACEUTICAL PREPARATIONSwww.prothena.com ↗
Price9.27
Change-1.38%
Gap+0.90%
Rel volume3.27×
Avg volume606.6K
Avg $ vol5.42M
SMA 208.93
SMA 509.79
SMA 2009.66
Price vs 50-5.30%
Price vs 200-3.99%
MA stackmixed
50/200 cross—
Supertrenddown · 9.74
RSI (14)52
MACD hist0.15
MACD crossbull · 4d
Stoch %K / %D72 / 80
ADX (14)19
+DI / −DI26 / 19
RSI divergence—
MACD divergenceBullish
ATR %+5.68%
ADR %5.70%
52w high11.51
52w low5.99
From 52w high-19.46%
Above 52w low+54.76%
New 52w highNo
SqueezeOff
Bollinger width27.56%
%B0.64
Donchian pos61.48%
Donchian high10.24
Donchian low7.73
AVWAP (52w high)9.31
vs AVWAP high-0.42%
AVWAP (52w low)8.91
vs AVWAP low+4.04%
OBV trendFlat
Chaikin MF (20)-0.18
Today vs 20d3.27×
Avg vol (14d)668.14K
Avg vol (20d)606.6K
Avg $ vol (20d)5.42M
Market cap485.31M
RS 3m (vs SPY)-4.58%
RS 6m (vs SPY)-5.67%
RS line new highNo
Trend template3/8
Technical rank32.3
1 week+9.19%
1 month-7.85%
3 months-0.43%
6 months-4.24%
1 year+52.72%
YTD+0.76%
P/E-1.99
P/B1.55
P/S50.12
P/FCF—
EPS-4.53
Div yield—
ROE-78.08%
ROA-69.76%
Debt/Eq—
Current10.43
EV/EBITDA-0.73
Gross margin—
Net margin—
Rev growth-92.84%
EPS growth-99.57%
Price target21.40
Target upside130.85%
Analyst ratingBuy
Institutional95.05%
Ent. value155.85M
Revenue51.08M
Net income32.72M
Gross profit—
Free cash flow—
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees67
ListedTue, Dec 18, 2012
Free float42.2M
Float %80.6%
Short interest7.74M
Days to cover13.8d
Short volume67.7%
Squeeze score95 / 100
Next earningsMon, Aug 3, 2026 (39d)
EPS forecast−$0.39 · 3 est
Last EPS vs est$0.52 vs −$0.31
Last surprise+267.7% beat
Setup gradeC
Conviction50 / 100
Pattern quality—
Tech rank32.3 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance11.03
Support7.79
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PRTA

All disclosures →
No recent disclosed trades by Congress in PRTA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PRTA · 7 buys

InsiderSideShares
SCULLY WILLIAM P
10% owner · Ordinary Shares, par value $0.01 per share · 2026-06-16
Buy20K
SCULLY WILLIAM P
10% owner · Ordinary Shares, par value $0.01 per share · 2026-06-04
Other—
SCULLY WILLIAM P
10% owner · Ordinary Shares, par value $0.01 per share · 2026-06-04
Buy50K
SCULLY WILLIAM P
10% owner · Ordinary Shares, par value $0.01 per share · 2026-06-02
Other—
SCULLY WILLIAM P
10% owner · Ordinary Shares, par value $0.01 per share · 2026-06-02
Buy50K
SCULLY WILLIAM P
10% owner · Ordinary Shares, par value $0.01 per share · 2026-05-22
Other—
SCULLY WILLIAM P
10% owner · Ordinary Shares, par value $0.01 per share · 2026-05-22
Buy100K
WELCH DANIEL G
Director · Stock Option (Right to Buy) · 2026-05-15
Grant27K
Dunn William H. Jr.
Director · Stock Option (Right to Buy) · 2026-05-15
Grant27K
COLLIER RICHARD T
Director · Stock Option (Right to Buy) · 2026-05-15
Grant27K

SEC filings

EDGAR filings in PRTA · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.